Currently approved GLP-1 therapies are primarily peptide-based injectables, with once-weekly administration being the main approach
PlexusDx works with licensed 503A compounding pharmacies to provide semaglutide injections that are $189/mo month-to-month, or from $149/mo on the 6-month plan, making this proven therapy accessible without insurance requirements
Cuando evales la atencin al cliente, considera la disponibilidad de chat en vivo, la rapidez de respuesta y la calidad de la base de conocimiento
That means the real impacts could be greater
These are compounded medications, dosed and monitored by our provider
For many patients, especially those with type 2 diabetes, obesity, or weight-related health concerns, these medications can be powerful tools when prescribed and monitored appropriately